|Articles|November 1, 2019
- BioPharm International-11-01-2019
- Volume 32
- Issue 11
BioPharm International, November 2019 Issue (PDF)
Click the title above to open the BioPharm International November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Biopharma modeling, now and five years from nowabout 6 years ago
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EUabout 6 years ago
Modeling Comes of Age in Biopharmaabout 6 years ago
Applying Lessons Learned from the Semiconductor Industryabout 6 years ago
What’s New in Manufacturing: Downstream Technologiesabout 6 years ago
KUBio Box for Viral Vectorsabout 6 years ago
Zippered Lab Coatabout 6 years ago
More Consistent Drug Inspection System on Horizonabout 6 years ago
Signatures–What’s in a Name?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
5
